Redemplo’s approval in familial chylomicronemia syndrome places the drug in competition with Ionis’ Tryngolza.

Alkermes will likely proceed with its planned acquisition of Avadel, which experienced an unexpected hitch following Lundbeck ...

SanegeneBio pipeline features experimental treatments for cardiometabolic conditions, kidney diseases and obesity. Credit: ...

The US FDA has granted approval for AbbVie’s Epkinly to treat adult patients with relapsed or refractory (R/R) follicular ...

CSL said the investment reflects the growing need for immunoglobulin, though it did not reveal detailed manufacturing plans.

The US Patent and Trademark Office (USPTO) has granted a patent to Genprex for the use of its Reqorsa gene therapy ...

Experts from Sharp offer insights into sustainable practices in pharma packaging, highlighting advancements achieved and ...

Insmed has received approval from the EC for Brinsupri to treat NCFB in patients aged 12 and above with two or more ...

Eleva’s CEO says CHO cell line alternatives could become common in therapeutic protein manufacturing, as large molecule drugs become complex and harder to produce at scale.

Italvacuum, a leading manufacturer of vacuum pumps and industrial drying systems for the pharmaceutical and fine chemical industries, announced its participation at CPHI | PMEC India 2025, taking ...

Johnson & Johnson has signed a definitive agreement for the acquisition of Halda Therapeutics (Halda) in a deal valued at ...

In a year where ADC deals have showed no signs of slowing, Solve has become the latest biotech to unlock an extra slice of capital.